| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Broadcom, Inc. | Equity | 13,015,464 | $4,570,900,802.00 | 3.65% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | Equity | 58,072,564 | $4,524,732,048.00 | 3.61% |
| Capital Group Central Cash Fund | Short Term | 44,930,704 | $4,492,171,817.00 | 3.59% |
| Philip Morris International, Inc. | Equity | 20,239,323 | $3,862,067,615.00 | 3.08% |
| AbbVie, Inc. | Equity | 9,965,860 | $2,606,969,317.00 | 2.08% |
| Capital Group Central Corporate Bond Fund | Investment Fund | 327,927,425 | $2,600,464,483.00 | 2.08% |
| British American Tobacco PLC | Equity | 39,093,559 | $2,140,151,350.00 | 1.71% |
| RTX Corp. | Equity | 9,491,160 | $1,762,033,854.00 | 1.41% |
| ExxonMobil Holdings Corp. | Equity | 9,594,682 | $1,561,534,496.00 | 1.25% |
| Gilead Sciences, Inc. | Equity | 9,382,560 | $1,398,470,568.00 | 1.12% |
| Canadian Natural Resources, Ltd. | Equity | 29,464,047 | $1,385,678,717.00 | 1.11% |
| JPMorgan Chase & Co. | Equity | 4,018,787 | $1,329,535,303.00 | 1.06% |
| U.S. Treasury 4.375% 8/31/2031 | Fixed Income | 1,286,000,000 | $1,247,721,438.00 | 1% |
| AstraZeneca PLC | Equity | 7,363,875 | $1,198,944,748.00 | 0.96% |
| Microsoft Corp. | Equity | 2,050,977 | $1,051,946,103.00 | 0.84% |